Adhesion Barriers Market Trends 2021 | Industry Growth, Share, Size, Demand and Future Scope 2026
According to IMARC Group’s latest report, the global adhesion barriers market exhibited moderate growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 7% during (2021-2026).
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Adhesion barriers are medical implants that are utilized to reduce post-surgical internal scarring by separating the tissues and organs. They assist in lowering common risks, such as chronic pain, infertility and bowel obstruction, during different surgeries. At present, they are available in the form of gel, film and liquid formulations across the globe.
Get Sample Report with Detail COVID-19 Impact Analysis - https://www.imarcgroup.com/adhesion-barriers-market/requestsample
Market Trends
The increasing prevalence of chronic diseases, coupled with the rising number of surgical procedures, represents one of the key factors impelling the global adhesion barriers market growth. Furthermore, the rising number of sports-related injuries and the rising geriatric population are further bolstering the market growth. Several medical associations are spreading awareness about post-surgical adhesion formation and available products, such as adhesion barriers, which is acting as another major growth-inducing factor. Other factors, such as rising healthcare investments and the advent of the sheet- and spray-type adhesion barriers that are more effective and convenient to use during laparoscopic procedures, are expected to drive the market growth in the upcoming years.
Buy Full Report with Detail Analysis with COVID-19 Impact – https://www.imarcgroup.com/adhesion-barriers-market
List of Key Companies Covered in this Market Report:
- Anika Therapeutics Inc.
- Atrium Medical Corporation
- Baxter International
- Betatech Medikal
- C. R. Bard, FzioMed Inc.
- Integra Lifesciences
- Johnson & Johnson
- MAST Biosurgery Inc.
- Sanofi
The report has segmented the market on the basis of product, formulation, application and geography.
Breakup by Product:
- Synthetic
- Natural
Breakup by Formulation:
- Film Formulations
- Liquid Formulations
- Gel Formulations
Breakup by Application:
- Gynecological Surgeries
- General/Abdominal Surgeries
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Reconstructive Surgeries
- Urological Surgeries
- Others
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Comments
Post a Comment